The somatostatin receptor in human pancreatic β-cells

Vitamins and Hormones

Volumn 95, Issue , 2014, Pages 165-193

  Braun, Matthias ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Diabetes; Exocytosis; Glucagon; Insulin; Ion channels; Pancreatic islets; Somatostatin; Somatostatin receptor; Cells

Indexed keywords

GLUCAGON; INSULIN; SOMATOSTATIN; SOMATOSTATIN RECEPTOR; SOMATOSTATIN RECEPTOR SUBTYPE 2, HUMAN;

AGONISTS; ANIMAL; BIOLOGICAL MODEL; CELL COMMUNICATION; HUMAN; METABOLISM; PANCREAS ISLET ALPHA CELL; PANCREAS ISLET BETA CELL; SECRETION (PROCESS); SOMATOSTATIN CELL;

ANIMALS; CELL COMMUNICATION; GLUCAGON; GLUCAGON-SECRETING CELLS; HUMANS; INSULIN; INSULIN-SECRETING CELLS; MODELS, BIOLOGICAL; RECEPTORS, SOMATOSTATIN; SOMATOSTATIN; SOMATOSTATIN-SECRETING CELLS;

EID: 84894043264     PISSN: 00836729     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-800174-5.00007-7     Document Type: Chapter

References (138)

1. Ahren B., Taborsky G.J. Effects of pancreatic noradrenaline infusion on basal and stimulated islet hormone secretion in the dog. Acta Physiologica Scandinavica 1988, 132(2):143-150.
2. Alberti K.G., Christensen N.J., Christensen S.E., Hansen A.P., Iversen J., Lundbaek K., et al. Inhibition of insulin secretion by somatostatin. Lancet 1973, 2(7841):1299-1301.
3. Ämmälä C., Ashcroft F.M., Rorsman P. Calcium-independent potentiation of insulin release by cyclic AMP in single beta-cells. Nature 1993, 363(6427):356-358.
4. Arnoux J.B., Verkarre V., Saint-Martin C., Montravers F., Brassier A., Valayannopoulos V., et al. Congenital hyperinsulinism: Current trends in diagnosis and therapy. Orphanet Journal of Rare Diseases 2011, 6:63.
5. Barbieri F., Bajetto A., Pattarozzi A., Gatti M., Wurth R., Thellung S., et al. Peptide receptor targeting in cancer: The somatostatin paradigm. International Journal of Peptide 2013, 2013:926295.
6. Barnett P. Somatostatin and somatostatin receptor physiology. Endocrine 2003, 20(3):255-264.
7. Berts A., Liu Y.J., Gylfe E., Hellman B. Oscillatory Ca2+ signaling in somatostatin-producing cells from the human pancreas. Metabolism 1997, 46(4):366-369.
8. Boron W.F., Boulpaep E.L. Medical Physiology: A Cellular and Molecular Approach 2012, Saunders, Philadelphia, PA. 2nd ed.
9. Bosco D., Armanet M., Morel P., Niclauss N., Sgroi A., Muller Y.D., et al. Unique arrangement of alpha- and beta-cells in human islets of Langerhans. Diabetes 2010, 59(5):1202-1210.
10. Braun M., Ramracheya R., Amisten S., Bengtsson M., Moritoh Y., Zhang Q., et al. Somatostatin release, electrical activity, membrane currents and exocytosis in human pancreatic delta cells. Diabetologia 2009, 52(8):1566-1578.
11. Braun M., Ramracheya R., Bengtsson M., Clark A., Walker J.N., Johnson P.R., et al. Gamma-aminobutyric acid (GABA) is an autocrine excitatory transmitter in human pancreatic beta-cells. Diabetes 2010, 59(7):1694-1701.
12. Braun M., Ramracheya R., Johnson P.R., Rorsman P. Exocytotic properties of human pancreatic beta-cells. Annals of the New York Academy of Sciences 2009, 1152:187-193.
13. Brazeau P., Vale W., Burgus R., Ling N., Butcher M., Rivier J., et al. Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone. Science 1973, 179(4068):77-79.
14. Brissova M., Fowler M.J., Nicholson W.E., Chu A., Hirshberg B., Harlan D.M., et al. Assessment of human pancreatic islet architecture and composition by laser scanning confocal microscopy. The Journal of Histochemistry and Cytochemistry 2005, 53(9):1087-1097.
15. Brunicardi F.C., Atiya A., Moldovan S., Lee T.C., Fagan S.P., Kleinman R.M., et al. Activation of somatostatin receptor subtype 2 inhibits insulin secretion in the isolated perfused human pancreas. Pancreas 2003, 27(4):e84-e89.
16. Brunicardi F.C., Kleinman R., Moldovan S., Nguyen T.H., Watt P.C., Walsh J., et al. Immunoneutralization of somatostatin, insulin, and glucagon causes alterations in islet cell secretion in the isolated perfused human pancreas. Pancreas 2001, 23(3):302-308.
17. Bruno J.F., Xu Y., Song J., Berelowitz M. Molecular cloning and functional expression of a brain-specific somatostatin receptor. Proceedings of the National Academy of Sciences of the United States of America 1992, 89(23):11151-11155.
18. Bruns C., Lewis I., Briner U., Meno-Tetang G., Weckbecker G. SOM230: A novel somatostatin peptidomimetic with broad somatotropin release inhibiting factor (SRIF) receptor binding and a unique antisecretory profile. European Journal of Endocrinology 2002, 146(5):707-716.
19. Bruttomesso D., Fongher C., Silvestri B., Barberio S., Marescotti M.C., Iori E., et al. Combination of continuous subcutaneous infusion of insulin and octreotide in Type 1 diabetic patients. Diabetes Research and Clinical Practice 2001, 51(2):97-105.
20. Cabrera O., Berman D.M., Kenyon N.S., Ricordi C., Berggren P.O., Caicedo A. The unique cytoarchitecture of human pancreatic islets has implications for islet cell function. Proceedings of the National Academy of Sciences of the United States of America 2006, 103(7):2334-2339.
21. Cabrera O., Jacques-Silva M.C., Speier S., Yang S.N., Kohler M., Fachado A., et al. Glutamate is a positive autocrine signal for glucagon release. Cell Metabolism 2008, 7(6):545-554.
22. Caicedo A. Paracrine and autocrine interactions in the human islet: More than meets the eye. Seminars in Cell & Developmental Biology 2012, 24(1):11-21.
23. Catterall W.A. Voltage-gated calcium channels. Cold Spring Harbor Perspectives in Biology 2011, 3(8):a003947.
24. Cejvan K., Coy D.H., Efendic S. Intra-islet somatostatin regulates glucagon release via type 2 somatostatin receptors in rats. Diabetes 2003, 52(5):1176-1181.
25. Cervia D., Bagnoli P. An update on somatostatin receptor signaling in native systems and new insights on their pathophysiology. Pharmacology & Therapeutics 2007, 116(2):322-341.
26. Chen X.K., Wang L.C., Zhou Y., Cai Q., Prakriya M., Duan K.L., et al. Activation of GPCRs modulates quantal size in chromaffin cells through G(betagamma) and PKC. Nature Neuroscience 2005, 8(9):1160-1168.
27. Cheng H., Straub S.G., Sharp G.W. Protein acylation in the inhibition of insulin secretion by norepinephrine, somatostatin, galanin, and PGE2. American Journal of Physiology Endocrinology and Metabolism 2003, 285(2):E287-E294.
28. Cheng-Xue R., Gomez-Ruiz A., Antoine N., Noel L.A., Chae H.Y., Ravier M.A., et al. Tolbutamide controls glucagon release from mouse islets differently than glucose: Involvement of KATP channels from both alpha-cells and delta-cells. Diabetes 2013, 62:1612-1622.
29. Clark A., Wells C.A., Buley I.D., Cruickshank J.K., Vanhegan R.I., Matthews D.R., et al. Islet amyloid, increased A-cells, reduced B-cells and exocrine fibrosis: Quantitative changes in the pancreas in type 2 diabetes. Diabetes Research 1988, 9(4):151-159.
30. Claro A., Grill V., Efendic S., Luft R. Studies on the mechanisms of somatostatin action on insulin release. IV. Effect of somatostatin on cyclic AMP levels and phosphodiesterase activity in isolated rat pancreatic islets. Acta Endocrinologica 1977, 85(2):379-388.
31. Cooperberg B.A., Cryer P.E. Beta-cell-mediated signaling predominates over direct alpha-cell signaling in the regulation of glucagon secretion in humans. Diabetes Care 2009, 32(12):2275-2280.
32. Csaba Z., Peineau S., Dournaud P. Molecular mechanisms of somatostatin receptor trafficking. Journal of Molecular Endocrinology 2012, 48(1):R1-R12.
33. D'Alessio D.A., Ensinck J.W. Fasting and postprandial concentrations of somatostatin-28 and somatostatin-14 in type II diabetes in men. Diabetes 1990, 39(10):1198-1202.
34. D'Alessio D.A., Sieber C., Beglinger C., Ensinck J.W. A physiologic role for somatostatin 28 as a regulator of insulin secretion. The Journal of Clinical Investigation 1989, 84(3):857-862.
35. Daunt M., Dale O., Smith P.A. Somatostatin inhibits oxidative respiration in pancreatic beta-cells. Endocrinology 2006, 147(3):1527-1535.
36. de Bruin C., Pereira A.M., Feelders R.A., Romijn J.A., Roelfsema F., Sprij-Mooij D.M., et al. Coexpression of dopamine and somatostatin receptor subtypes in corticotroph adenomas. The Journal of Clinical Endocrinology and Metabolism 2009, 94(4):1118-1124.
37. de Heer J., Rasmussen C., Coy D.H., Holst J.J. Glucagon-like peptide-1, but not glucose-dependent insulinotropic peptide, inhibits glucagon secretion via somatostatin (receptor subtype 2) in the perfused rat pancreas. Diabetologia 2008, 51(12):2263-2270.
38. De Marinis Y.Z., Salehi A., Ward C.E., Zhang Q., Abdulkader F., Bengtsson M., et al. GLP-1 inhibits and adrenaline stimulates glucagon release by differential modulation of N- and L-type Ca2+ channel-dependent exocytosis. Cell Metabolism 2010, 11(6):543-553.
39. Dunning B.E., Gerich J.E. The role of alpha-cell dysregulation in fasting and postprandial hyperglycemia in type 2 diabetes and therapeutic implications. Endocrine Reviews 2007, 28(3):253-283.
40. Efendic S., Claro A., Laft R. Studies on the mechanism of somatostatin action on insulin release. III. Effect of somatostatin on arginine induced release of insulin and glucagon in man and perfused rat pancreas. Acta Endocrinologica 1976, 81(4):753-761.
41. Efendic S., Enzmann F., Nylen A., Uvnas-Wallensten K., Luft R. Effect of glucose/sulfonylurea interaction on release of insulin, glucagon, and somatostatin from isolated perfused rat pancreas. Proceedings of the National Academy of Sciences of the United States of America 1979, 76(11):5901-5904.
42. Ensinck J.W., Laschansky E.C., Vogel R.E., Simonowitz D.A., Roos B.A., Francis B.H. Circulating prosomatostatin-derived peptides. Differential responses to food ingestion. The Journal of Clinical Investigation 1989, 83(5):1580-1589.
43. Gaisano H.Y., Macdonald P.E., Vranic M. Glucagon secretion and signaling in the development of diabetes. Frontiers in Physiology 2012, 3:349.
44. Gerber P.P., Trimble E.R., Wollheim C.B., Renold A.E. Effect of insulin on glucose- and arginine-stimulated somatostatin secretion from the isolated perfused rat pancreas. Endocrinology 1981, 109(1):279-283.
45. Gerich J.E. Somatostatin modulation of glucagon secretion and its importance in human glucose homeostasis. Metabolism 1978, 27(9 Suppl. 1):1283-1290.
46. Gopel S.O., Kanno T., Barg S., Rorsman P. Patch-clamp characterisation of somatostatin-secreting -cells in intact mouse pancreatic islets. The Journal of Physiology 2000, 528(Pt 3):497-507.
47. Gopel S., Zhang Q., Eliasson L., Ma X.S., Galvanovskis J., Kanno T., et al. Capacitance measurements of exocytosis in mouse pancreatic {alpha}-, {beta}- and {delta}-cells studied in intact islets of Langerhans. The Journal of Physiology 2004, 556:711-726.
48. Grill V., Gutniak M., Roovete A., Efendic S. A stimulating effect of glucose on somatostatin release is impaired in noninsulin-dependent diabetes mellitus. The Journal of Clinical Endocrinology and Metabolism 1984, 59(2):293-297.
49. Gromada J., Hoy M., Buschard K., Salehi A., Rorsman P. Somatostatin inhibits exocytosis in rat pancreatic alpha-cells by G(i2)-dependent activation of calcineurin and depriming of secretory granules. The Journal of Physiology 2001, 535(Pt 2):519-532.
50. Gromada J., Hoy M., Olsen H.L., Gotfredsen C.F., Buschard K., Rorsman P., et al. Gi2 proteins couple somatostatin receptors to low-conductance K+channels in rat pancreatic alpha-cells. Pflügers Archiv 2001, 442(1):19-26.
51. Gutniak M., Grill V., Roovete A., Efendic S. Impaired somatostatin response to orally administered glucose in type II diabetes entails both somatostatin-28 and -14 and is associated with deranged metabolic control. Acta Endocrinologica 1989, 121(3):322-326.
52. Gutniak M., Grill V., Wiechel K.L., Efendic S. Basal and meal-induced somatostatin-like immunoreactivity in healthy subjects and in IDDM and totally pancreatectomized patients. Effects of acute blood glucose normalization. Diabetes 1987, 36(7):802-807.
53. Hahn H.J., Gottschling H.D., Woltanski P. Effect of somatostatin on insulin secretion and cAMP content of isolated pancreatic rat islets. Metabolism 1978, 27(9 Suppl. 1):1291-1294.
54. Hauge-Evans A.C., Anderson R.L., Persaud S.J., Jones P.M. Delta cell secretory responses to insulin secretagogues are not mediated indirectly by insulin. Diabetologia 2012, 55(7):1995-2004.
55. Hauge-Evans A.C., King A.J., Carmignac D., Richardson C.C., Robinson I.C., Low M.J., et al. Somatostatin secreted by islet {delta}-cells fulfils multiple roles as a paracrine regulator of islet function. Diabetes 2008, 58:403-411.
56. Hauge-Evans A.C., King A.J., Fairhall K., Persaud S.J., Jones P.M. A role for islet somatostatin in mediating sympathetic regulation of glucagon secretion. Islets 2010, 2(6):341-344.
57. Hellman B., Salehi A., Gylfe E., Dansk H., Grapengiesser E. Glucose generates coincident insulin and somatostatin pulses and antisynchronous glucagon pulses from human pancreatic islets. Endocrinology 2009, 150(12):5334-5340.
58. Henquin J.C., Dufrane D., Nenquin M. Nutrient control of insulin secretion in isolated normal human islets. Diabetes 2006, 55(12):3470-3477.
59. Hermansen K., Orskov H., Christensen S.E. Streptozotocin diabetes: A glucoreceptor dysfunction affecting D cells as well as B and A cells. Diabetologia 1979, 17(6):385-389.
60. Hibino H., Inanobe A., Furutani K., Murakami S., Findlay I., Kurachi Y. Inwardly rectifying potassium channels: Their structure, function, and physiological roles. Physiological Reviews 2010, 90(1):291-366.
61. Hunyady B., Hipkin R.W., Schonbrunn A., Mezey E. Immunohistochemical localization of somatostatin receptor SST2A in the rat pancreas. Endocrinology 1997, 138(7):2632-2635.
62. Iki K., Pour P.M. Distribution of pancreatic endocrine cells including IAPP-expressing cells in non-diabetic and type 2 diabetic cases. The Journal of Histochemistry and Cytochemistry 2007, 55(2):111-118.
63. Ipp E., Dobbs R.E., Arimura A., Vale W., Harris V., Unger R.H. Release of immunoreactive somatostatin from the pancreas in response to glucose, amino acids, pancreozymin-cholecystokinin, and tolbutamide. The Journal of Clinical Investigation 1977, 60(3):760-765.
64. Kailey B., van de Bunt M., Cheley S., Johnson P.R., Macdonald P.E., Gloyn A.L., et al. SSTR2 is the functionally dominant somatostatin receptor in human pancreatic beta- and alpha-cells. American Journal of Physiology Endocrinology and Metabolism 2012, 303:E1107-E1116.
65. Kimura N., Schindler M., Kasai N., Kimura I. Immunohistochemical localization of somatostatin receptor type 2A in rat and human tissues. Endocrine Journal 2001, 48(1):95-102.
66. Kirkegaard C., Norgaard K., Snorgaard O., Bek T., Larsen M., Lund-Andersen H. Effect of one year continuous subcutaneous infusion of a somatostatin analogue, octreotide, on early retinopathy, metabolic control and thyroid function in Type I (insulin-dependent) diabetes mellitus. Acta Endocrinologica 1990, 122(6):766-772.
67. Kleinman R., Ohning G., Wong H., Watt P., Walsh J., Brunicardi F.C. Regulatory role of intraislet somatostatin on insulin secretion in the isolated perfused human pancreas. Pancreas 1994, 9(2):172-178.
68. Kubota A., Yamada Y., Kagimoto S., Shimatsu A., Imamura M., Tsuda K., et al. Identification of somatostatin receptor subtypes and an implication for the efficacy of somatostatin analogue SMS 201-995 in treatment of human endocrine tumors. The Journal of Clinical Investigation 1994, 93(3):1321-1325.
69. Kumar U., Sasi R., Suresh S., Patel A., Thangaraju M., Metrakos P., et al. Subtype-selective expression of the five somatostatin receptors (hSSTR1-5) in human pancreatic islet cells: A quantitative double-label immunohistochemical analysis. Diabetes 1999, 48(1):77-85.
70. Harrison's Principles of Internal Medicine 2012, McGraw-Hill, New York, NY. 18th ed. D.L. Longo, S. Fauci, D.L. Kasper, S.L. Hauser, J.L. Jameson, J. Loscalzo (Eds.).
71. Luft R., Efendic S., Hokfelt T., Johansson O., Arimura A. Immunohistochemical evidence for the localization of somatostatin-Like immunoreactivity in a cell population of the pancreatic islets. Medical Biology 1974, 52(6):428-430.
72. Lupp A., Hunder A., Petrich A., Nagel F., Doll C., Schulz S. Reassessment of sst(5) somatostatin receptor expression in normal and neoplastic human tissues using the novel rabbit monoclonal antibody UMB-4. Neuroendocrinology 2011, 94(3):255-264.
73. Lupp A., Nagel F., Doll C., Rocken C., Evert M., Mawrin C., et al. Reassessment of sst3 somatostatin receptor expression in human normal and neoplastic tissues using the novel rabbit monoclonal antibody UMB-5. Neuroendocrinology 2012, 96(4):301-310.
74. Mandarino L., Stenner D., Blanchard W., Nissen S., Gerich J., Ling N., et al. Selective effects of somatostatin-14, -25 and -28 on in vitro insulin and glucagon secretion. Nature 1981, 291(5810):76-77.
75. Mazziotti G., Floriani I., Bonadonna S., Torri V., Chanson P., Giustina A. Effects of somatostatin analogs on glucose homeostasis: A metaanalysis of acromegaly studies. The Journal of Clinical Endocrinology and Metabolism 2009, 94(5):1500-1508.
76. McKeage K. Pasireotide: A review of its use in Cushing's disease. Drugs 2013, 73:563-574.
77. Menge B.A., Gruber L., Jorgensen S.M., Deacon C.F., Schmidt W.E., Veldhuis J.D., et al. Loss of inverse relationship between pulsatile insulin and glucagon secretion in patients with type 2 diabetes. Diabetes 2011, 60(8):2160-2168.
78. Mergler S., Singh V., Grotzinger C., Kaczmarek P., Wiedenmann B., Strowski M.Z. Characterization of voltage operated R-type Ca2+ channels in modulating somatostatin receptor subtype 2- and 3-dependent inhibition of insulin secretion from INS-1 cells. Cellular Signalling 2008, 20(12):2286-2295.
79. Misler S., Dickey A., Barnett D.W. Maintenance of stimulus-secretion coupling and single beta-cell function in cryopreserved-thawed human islets of Langerhans. Pflügers Archiv 2005, 450(6):395-404.
80. Mitra S.W., Mezey E., Hunyady B., Chamberlain L., Hayes E., Foor F., et al. Colocalization of somatostatin receptor sst5 and insulin in rat pancreatic beta-cells. Endocrinology 1999, 140(8):3790-3796.
81. Molina J., Fachado A., Menegaz D., Berggren P.O., Caicedo A. Paracrine regulation of human delta-cells is impaired in type 2 diabetes. Diabetes 2012, 61(Suppl. 1A):145-LB.
82. Moller L.N., Stidsen C.E., Hartmann B., Holst J.J. Somatostatin receptors. Biochimica et Biophysica Acta 2003, 1616(1):1-84.
83. Moss C.E., Marsh W.J., Parker H.E., Ogunnowo-Bada E., Riches C.H., Habib A.M., et al. Somatostatin receptor 5 and cannabinoid receptor 1 activation inhibit secretion of glucose-dependent insulinotropic polypeptide from intestinal K cells in rodents. Diabetologia 2012, 55(11):3094-3103.
84. Myint K.S., Greenfield J.R., Farooqi I.S., Henning E., Holst J.J., Finer N. Prolonged successful therapy for hyperinsulinaemic hypoglycaemia after gastric bypass: The pathophysiological role of GLP1 and its response to a somatostatin analogue. European Journal of Endocrinology 2012, 166(5):951-955.
85. O'Carroll A.M., Lolait S.J., Konig M., Mahan L.C. Molecular cloning and expression of a pituitary somatostatin receptor with preferential affinity for somatostatin-28. Molecular Pharmacology 1992, 42(6):939-946.
86. Orci L., Baetens D., Rufener C., Amherdt M., Ravazzola M., Studer P., et al. Hypertrophy and hyperplasia of somatostatin-containing D-cells in diabetes. Proceedings of the National Academy of Sciences of the United States of America 1976, 73(4):1338-1342.
87. Ostenson C.G., Efendic S., Grill V. Abnormal regulation by glucose of somatostatin secretion in the perfused pancreas of NIDDM rats. Pancreas 1990, 5(3):347-353.
88. Papotti M., Bongiovanni M., Volante M., Allia E., Landolfi S., Helboe L., et al. Expression of somatostatin receptor types 1-5 in 81 cases of gastrointestinal and pancreatic endocrine tumors. A correlative immunohistochemical and reverse-transcriptase polymerase chain reaction analysis. Virchows Archiv 2002, 440(5):461-475.
89. Park S., Jiang H., Zhang H., Smith R.G. Modification of ghrelin receptor signaling by somatostatin receptor-5 regulates insulin release. Proceedings of the National Academy of Sciences of the United States of America 2012, 109(46):19003-19008.
90. Patel Y.C. Somatostatin and its receptor family. Frontiers in Neuroendocrinology 1999, 20(3):157-198.
91. Patel Y.C., Greenwood M.T., Warszynska A., Panetta R., Srikant C.B. All five cloned human somatostatin receptors (hSSTR1-5) are functionally coupled to adenylyl cyclase. Biochemical and Biophysical Research Communications 1994, 198(2):605-612.
92. Patel Y.C., Reichlin S. Somatostatin in hypothalamus, extrahypothalamic brain, and peripheral tissues of the rat. Endocrinology 1978, 102(2):523-530.
93. Patel Y.C., Wheatley T. In vivo and in vitro plasma disappearance and metabolism of somatostatin-28 and somatostatin-14 in the rat. Endocrinology 1983, 112(1):220-225.
94. Patton G.S., Ipp E., Dobbs R.E., Orci L., Vale W., Unger R.H. Pancreatic immunoreactive somatostatin release. Proceedings of the National Academy of Sciences of the United States of America 1977, 74(5):2140-2143.
95. Portela-Gomes G.M., Grimelius L., Westermark P., Stridsberg M. Somatostatin receptor subtypes in human type 2 diabetic islets. Pancreas 2010, 39(6):836-842.
96. Rahier J., Goebbels R.M., Henquin J.C. Cellular composition of the human diabetic pancreas. Diabetologia 1983, 24(5):366-371.
97. Ramracheya R., Ward C., Shigeto M., Walker J.N., Amisten S., Zhang Q., et al. Membrane potential-dependent inactivation of voltage-gated ion channels in alpha-cells inhibits glucagon secretion from human islets. Diabetes 2010, 59(9):2198-2208.
98. Renstrom E., Ding W.G., Bokvist K., Rorsman P. Neurotransmitter-induced inhibition of exocytosis in insulin-secreting beta cells by activation of calcineurin. Neuron 1996, 17(3):513-522.
99. Rohrer S.P., Schaeffer J.M. Identification and characterization of subtype selective somatostatin receptor agonists. Journal of Physiology, Paris 2000, 94(3-4):211-215.
100. Rorsman P., Braun M. Regulation of insulin secretion in human pancreatic islets. Annual Review of Physiology 2013, 75:155-179.
101. Saito K., Yaginuma N., Takahashi T. Differential volumetry of A, B and D cells in the pancreatic islets of diabetic and nondiabetic subjects. The Tohoku Journal of Experimental Medicine 1979, 129(3):273-283.
102. Samols E., Stagner J.I., Ewart R.B., Marks V. The order of islet microvascular cellular perfusion is B--A--D in the perfused rat pancreas. The Journal of Clinical Investigation 1988, 82(1):350-353.
103. Schuit F.C., Pipeleers D.G. Regulation of adenosine 3',5'-monophosphate levels in the pancreatic B cell. Endocrinology 1985, 117(3):834-840.
104. Schwetz T.A., Ustione A., Piston D.W. Neuropeptide Y and somatostatin inhibit insulin secretion through different mechanisms. American Journal of Physiology. Endocrinology and Metabolism 2013, 304(2):E211-E221.
105. Segers O., De Vroede M., Michotte Y., Somers G. Basal and tolbutamide-induced plasma somatostatin in healthy subjects and in patients with diabetes and impaired glucose tolerance. Diabetic Medicine 1989, 6(3):232-238.
106. Shapiro A.M., Lakey J.R., Ryan E.A., Korbutt G.S., Toth E., Warnock G.L., et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. The New England Journal of Medicine 2000, 343(4):230-238.
107. Sherwin R.S., Hendler R., DeFronzo R., Wahren J., Felic P. Glucose homeostasis during prolonged suppression of glucagon and insulin secretion by somatostatin. Proceedings of the National Academy of Sciences of the United States of America 1977, 74(1):348-352.
108. Singh V., Brendel M.D., Zacharias S., Mergler S., Jahr H., Wiedenmann B., et al. Characterization of somatostatin receptor subtype-specific regulation of insulin and glucagon secretion: An in vitro study on isolated human pancreatic islets. The Journal of Clinical Endocrinology and Metabolism 2007, 92(2):673-680.
109. Skare S., Dahl-Jorgensen K., Hanssen K.F., Norman N. Increased peripheral venous somatostatin concentration and decreased glucagon response to arginine in patients with insulin dependent diabetes mellitus without residual B-cell function. Increased plasma SRIF in IDDM. Acta Endocrinologica 1985, 109(4):517-521.
110. Smith P.A. N-type Ca(2+) -channels in murine pancreatic beta-cells are inhibited by an exclusive coupling with somatostatin receptor subtype 1. Endocrinology 2009, 150(2):741-748.
111. Smith P.A., Sellers L.A., Humphrey P.P. Somatostatin activates two types of inwardly rectifying K+channels in MIN-6 cells. The Journal of Physiology 2001, 532(Pt 1):127-142.
112. Stefan Y., Orci L., Malaisse-Lagae F., Perrelet A., Patel Y., Unger R.H. Quantitation of endocrine cell content in the pancreas of nondiabetic and diabetic humans. Diabetes 1982, 31(8 Pt 1):694-700.
113. Strowski M.Z., Blake A.D. Function and expression of somatostatin receptors of the endocrine pancreas. Molecular and Cellular Endocrinology 2008, 286(1-2):169-179.
114. Strowski M.Z., Kohler M., Chen H.Y., Trumbauer M.E., Li Z., Szalkowski D., et al. Somatostatin receptor subtype 5 regulates insulin secretion and glucose homeostasis. Molecular Endocrinology 2003, 17(1):93-106.
115. Strowski M.Z., Parmar R.M., Blake A.D., Schaeffer J.M. Somatostatin inhibits insulin and glucagon secretion via two receptors subtypes: An in vitro study of pancreatic islets from somatostatin receptor 2 knockout mice. Endocrinology 2000, 141(1):111-117.
116. Taniyama Y., Suzuki T., Mikami Y., Moriya T., Satomi S., Sasano H. Systemic distribution of somatostatin receptor subtypes in human: An immunohistochemical study. Endocrine Journal 2005, 52(5):605-611.
117. Tengholm A., Gylfe E. Oscillatory control of insulin secretion. Molecular and Cellular Endocrinology 2009, 297(1-2):58-72.
118. Thaler J.P., Cummings D.E. Minireview: Hormonal and metabolic mechanisms of diabetes remission after gastrointestinal surgery. Endocrinology 2009, 150(6):2518-2525.
119. Trimble E.R., Gerber P.P., Renold A.E. Abnormalities of pancreatic somatostatin secretion corrected by in vivo insulin treatment of streptozotocin-diabetic rats. Diabetes 1981, 30(10):865-867.
120. Tulipano G., Schulz S. Novel insights in somatostatin receptor physiology. European Journal of Endocrinology 2007, 156(Suppl. 1):S3-S11.
121. Unger R.H., Cherrington A.D. Glucagonocentric restructuring of diabetes: A pathophysiologic and therapeutic makeover. The Journal of Clinical Investigation 2012, 122(1):4-12.
122. van der Hoek J., van der Lelij A.J., Feelders R.A., de Herder W.W., Uitterlinden P., Poon K.W., et al. The somatostatin analogue SOM230, compared with octreotide, induces differential effects in several metabolic pathways in acromegalic patients. Clinical Endocrinology 2005, 63(2):176-184.
123. Vanetti M., Kouba M., Wang X., Vogt G., Hollt V. Cloning and expression of a novel mouse somatostatin receptor (SSTR2B). FEBS Letters 1992, 311(3):290-294.
124. Velasquez-Mieyer P.A., Umpierrez G.E., Lustig R.H., Cashion A.K., Cowan P.A., Christensen M., et al. Race affects insulin and GLP-1 secretion and response to a long-acting somatostatin analogue in obese adults. International Journal of Obesity and Related Metabolic Disorders 2004, 28(2):330-333.
125. Viana F., Hille B. Modulation of high voltage-activated calcium channels by somatostatin in acutely isolated rat amygdaloid neurons. The Journal of Neuroscience 1996, 16(19):6000-6011.
126. Walker J.N., Ramracheya R., Zhang Q., Johnson P.R., Braun M., Rorsman P. Regulation of glucagon secretion by glucose: Paracrine, intrinsic or both?. Diabetes, Obesity and Metabolism 2011, 13(Suppl. 1):95-105.
127. Yamada Y., Kagimoto S., Kubota A., Yasuda K., Masuda K., Someya Y., et al. Cloning, functional expression and pharmacological characterization of a fourth (hSSTR4) and a fifth (hSSTR5) human somatostatin receptor subtype. Biochemical and Biophysical Research Communications 1993, 195(2):844-852.
128. Yamada Y., Post S.R., Wang K., Tager H.S., Bell G.I., Seino S. Cloning and functional characterization of a family of human and mouse somatostatin receptors expressed in brain, gastrointestinal tract, and kidney. Proceedings of the National Academy of Sciences of the United States of America 1992, 89(1):251-255.
129. Yamada Y., Reisine T., Law S.F., Ihara Y., Kubota A., Kagimoto S., et al. Somatostatin receptors, an expanding gene family: Cloning and functional characterization of human SSTR3, a protein coupled to adenylyl cyclase. Molecular Endocrinology 1992, 6(12):2136-2142.
130. Yang L., Berk S.C., Rohrer S.P., Mosley R.T., Guo L., Underwood D.J., et al. Synthesis and biological activities of potent peptidomimetics selective for somatostatin receptor subtype 2. Proceedings of the National Academy of Sciences of the United States of America 1998, 95(18):10836-10841.
131. Yasuda K., Rens-Domiano S., Breder C.D., Law S.F., Saper C.B., Reisine T., et al. Cloning of a novel somatostatin receptor, SSTR3, coupled to adenylylcyclase. The Journal of Biological Chemistry 1992, 267(28):20422-20428.
132. Yorifuji T., Kawakita R., Hosokawa Y., Fujimaru R., Matsubara K., Aizu K., et al. Efficacy and safety of long-term, continuous subcutaneous octreotide infusion for patients with different subtypes of KATP -channel hyperinsulinism. Clinical Endocrinology 2013, 78(6):891-897.
133. Yoshimoto Y., Fukuyama Y., Horio Y., Inanobe A., Gotoh M., Kurachi Y. Somatostatin induces hyperpolarization in pancreatic islet alpha cells by activating a G protein-gated K+channel. FEBS Letters 1999, 444(2-3):265-269.
134. Yue J.T., Burdett E., Coy D.H., Giacca A., Efendic S., Vranic M. Somatostatin receptor type 2 antagonism improves glucagon and corticosterone counterregulatory responses to hypoglycemia in streptozotocin-induced diabetic rats. Diabetes 2012, 61(1):197-207.
135. Zambre Y., Ling Z., Chen M.C., Hou X., Woon C.W., Culler M., et al. Inhibition of human pancreatic islet insulin release by receptor-selective somatostatin analogs directed to somatostatin receptor subtype 5. Biochemical Pharmacology 1999, 57(10):1159-1164.
136. Zhang Q., Bengtsson M., Partridge C., Salehi A., Braun M., Cox R., et al. R-type Ca(2+)-channel-evoked CICR regulates glucose-induced somatostatin secretion. Nature Cell Biology 2007, 9(4):453-460.
137. Zhao Y., Fang Q., Straub S.G., Lindau M., Sharp G.W. Noradrenaline inhibits exocytosis via the G protein betagamma subunit and refilling of the readily releasable granule pool via the alpha(i1/2) subunit. The Journal of Physiology 2010, 588(Pt 18):3485-3498.
138. Zhou G., Liu S.H., Shahi K.M., Wang H., Duan X., Lin X., et al. Negative regulation of pancreatic and duodenal homeobox-1 by somatostatin receptor subtype 5. Molecular Endocrinology 2012, 26(7):1225-1234.